1. Food and Drug Administration. Current good manufacturing practice in the manufacture, processing, packing, or holding of large volume parenterals—proposed rule. Federal Register. 1976;41(106):22202–18.
2. Food and Drug Administration. Use of aseptic processing and terminal sterilization in the preparation of sterile pharmaceuticals for human and veterinary use – proposed rule. Federal Register. 1991;56(1198):51354–58.
3. Food and Drug Administration. Withdrawal of certain proposed rules and other proposed actions. Federal Register. 2004;69(227):68831–38.
4. ICH. Guidance for Industry – Q8 (r2) Pharmaceutical Development. Food and Drug Administration. 2009.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073507.pdf
5. Centers for Disease Control and Prevention. Epidemiologic notes and reports. Nosocomial bacteremias associated with intravenous fluid therapy – USA. MMWR. 1997;45(51):1227–33.